Jeffrey P. Castelli joined Amicus in July 2005 and currently serves as Chief Portfolio Officer and Head of Gene Therapy. He brings over 15 years of experience in the Biotech and Orphan Drug industry, focused on program management, portfolio planning, business operations, and alliance management. After joining Amicus in 2005, he subsequently took on roles of increasing responsibility within business operations. In his current capacity, Dr. Castelli provides strategic guidance and oversight across all research and development activities, including direct responsibility for the Program Management, Portfolio Planning and Statistical Science functions. Prior to joining Amicus, Dr. Castelli was a healthcare strategy consultant at Health Advances LLC and also previously worked in business development at Neose Pharmaceuticals Inc.
Dr. Castelli received a B.S. from West Chester University and a Ph.D. from the University of Pennsylvania. He is also an author on numerous publications and several patents in the field of rare disease drug development.